FSHR and Infertility: For FSHR-related pharmacovariants, also the number of evidence would be the main criteria, but the fact that FSHR gene variants show potential influence on drug response through a change in ligand and exogenous agonist sensitivity still make it necessary to follow the genotyping approaches in order to predict the diverse outcome of the treatment for some special case of infertile women.